John Marcolini Sells 331 Shares of Itron (NASDAQ:ITRI) Stock

Key Points

• Itron SVP John Marcolini sold 331 shares at an average price of $98.79, totaling $32,699.49. The sale covered tax withholding obligations, and he retained 12,683 shares.
• Itron’s latest quarter beat earnings expectations, reporting $1.59 EPS versus the $1.29 consensus estimate, though revenue fell 7.2% year over year to $562.9 million. Management guided for full-year 2026 EPS of $6.30–$6.50.
• Wall Street remains generally positive, with a “Moderate Buy” consensus rating and an average price target of $131.33 versus the recent share price near $98.73. Institutional investors own 96.19% of the company.

Itron, Inc. (NASDAQ:ITRI - Get Free Report) SVP John Marcolini sold 331 shares of the firm's stock in a transaction on Monday, August 24th. The stock was sold at an average price of $98.79, for a total transaction of $32,699.49. Following the transaction, the senior vice president directly owned 12,683 shares in the company, valued at $1,252,953.57. The trade was a 2.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Itron Stock Performance

ITRI traded up $0.04 on Tuesday, hitting $98.73. 594,864 shares of the company traded hands, compared to its average volume of 879,926. The company has a 50 day moving average of $90.88 and a 200-day moving average of $90.09. The company has a quick ratio of 2.29, a current ratio of 2.75 and a debt-to-equity ratio of 0.96. The stock has a market capitalization of $4.32 billion, a PE ratio of 16.48, a PEG ratio of 1.20 and a beta of 1.30. Itron, Inc. has a 12-month low of $77.77 and a 12-month high of $142.00.

Itron (NASDAQ:ITRI - Get Free Report) last announced its earnings results on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.29 by $0.30. Itron had a return on equity of 19.26% and a net margin of 11.90%.The company had revenue of $562.90 million for the quarter, compared to the consensus estimate of $566.34 million. During the same period last year, the business posted $1.62 EPS. The company's revenue was down 7.2% on a year-over-year basis. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS. Sell-side analysts anticipate that Itron, Inc. will post 6.4 earnings per share for the current year.

Hedge Funds Weigh In On Itron

Institutional investors and hedge funds have recently made changes to their positions in the stock. EverSource Wealth Advisors LLC lifted its stake in shares of Itron by 25.3% in the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company's stock valued at $53,000 after purchasing an additional 81 shares during the period. Northwestern Mutual Wealth Management Co. grew its position in Itron by 29.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company's stock worth $41,000 after buying an additional 101 shares during the period. Impact Partnership Wealth LLC grew its position in Itron by 4.7% during the first quarter. Impact Partnership Wealth LLC now owns 2,661 shares of the scientific and technical instruments company's stock worth $239,000 after buying an additional 119 shares during the period. Xponance LLC increased its holdings in Itron by 3.2% in the fourth quarter. Xponance LLC now owns 3,877 shares of the scientific and technical instruments company's stock valued at $360,000 after buying an additional 120 shares in the last quarter. Finally, Maryland State Retirement & Pension System lifted its position in shares of Itron by 2.2% during the 4th quarter. Maryland State Retirement & Pension System now owns 6,718 shares of the scientific and technical instruments company's stock valued at $624,000 after acquiring an additional 146 shares during the period. 96.19% of the stock is owned by institutional investors and hedge funds.

More Itron News

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Wall Street remains broadly optimistic. Itron has a “Moderate Buy” consensus rating from eight Buy, four Hold and one Sell recommendation, with an average price target of $131.33—well above recent trading levels. Needham raised its target to $128, while Seaport Research Partners set a $150 target. Itron analyst ratings
• Positive Sentiment: Itron’s latest quarterly results exceeded expectations on earnings, reporting $1.59 per share versus the $1.29 consensus estimate. Management also guided for third-quarter 2026 EPS of $1.50–$1.60 and full-year EPS of $6.30–$6.50. Itron earnings and guidance
• Neutral Sentiment: Institutional ownership is high at 96.19%, and several large funds recently increased or initiated positions. That suggests continued institutional interest, although ownership changes do not necessarily indicate near-term buying pressure. Itron institutional ownership
• Negative Sentiment: CFO Joan S. Hooper sold 4,406 shares worth approximately $435,577, while several senior vice presidents and the chief accounting officer collectively sold 1,213 additional shares. The concentration of sales can weigh on sentiment, even though the executives retained substantial positions and identified tax withholding—not an open-market bearish bet—as the reason for the transactions. SEC insider transaction filing
• Negative Sentiment: Revenue in the latest quarter declined 7.2% year over year to $562.9 million, slightly below analyst expectations. This contraction may temper enthusiasm despite the earnings beat and current-year guidance. Itron quarterly results

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. Robert W. Baird set a $125.00 target price on shares of Itron in a research note on Wednesday, July 29th. Stephens reiterated an "overweight" rating and set a $130.00 price target on shares of Itron in a research note on Wednesday, May 20th. Zacks Research raised shares of Itron from a "strong sell" rating to a "hold" rating in a report on Wednesday, July 29th. Needham & Company LLC raised their price objective on shares of Itron from $116.00 to $128.00 and gave the company a "buy" rating in a research report on Wednesday, July 29th. Finally, Seaport Research Partners reaffirmed a "buy" rating and issued a $150.00 price objective on shares of Itron in a report on Wednesday, July 29th. Eight equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $131.33.

About Itron

Itron, Inc NASDAQ: ITRI is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company's offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron's product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source